MRI联合术前血清学指标及病理特征对早期宫颈癌淋巴结转移的预测价值

赵梦秋; 晋茂生; 刘红丽; 刘健

doi:10.16766/j.cnki.issn.1674-4152.002844

MRI联合术前血清学指标及病理特征对早期宫颈癌淋巴结转移的预测价值

doi: 10.16766/j.cnki.issn.1674-4152.002844

1.
蚌埠医学院第一附属医院妇产科，安徽蚌埠 233004
2.
蚌埠医学院第一附属医院肿瘤妇科

基金项目:

安徽省高校自然科学重点项目 KJ2019A0346

详细信息

通讯作者:
晋茂生，E-mail：676926817@qq.com

中图分类号: R737.33 R446
计量
- 文章访问数: 186
- HTML全文浏览量: 59
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2022-05-17
- 网络出版日期: 2023-04-20

Prediction of lymph node metastasis in early cervical cancer by MRI combined with preoperative serological indices and pathological features

1.
Department of Obstetrics and Gynecology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

摘要

摘要: 目的探讨MRI与术前血清学指标鳞状细胞癌抗原(SCC-Ag)、中性粒细胞与淋巴细胞比值(NLR)及活检病理联合对早期宫颈癌淋巴结转移(LNM)的预测价值。方法选取2019年1月—2022年2月在蚌埠医学院第一附属医院行初次手术的宫颈癌患者307例，按术后病理是否存在淋巴结转移分为淋巴结转移组81例和未转移组226例，比较2组患者的MRI淋巴结短径、肿瘤直径、间质浸润深度、宫旁浸润和阴道受累，术前血清学指标以及病理特征。分析联合诊断对淋巴结转移的预测价值。结果 Logistic回归分析显示MRI淋巴结短径大、MRI肿瘤直径大、MRI间质浸润深度>1/2肌层、MRI宫旁浸润、术前SCC-Ag水平升高和脉管浸润是宫颈癌淋巴结转移的独立危险因素(均P < 0.05)。MRI淋巴结短径、术前SCC-Ag水平、NLR诊断宫颈癌LNM的ROC曲线下面积分别为0.806、0.711、0.630，最佳截断值分别为8.50 mm、2.55 ng/mL、1.90，灵敏度分别为0.654、0.593、0.593，特异度分别为0.881、0.757、0.642；MRI淋巴结短径联合SCC-Ag诊断的ROC曲线下面积为0.846；MRI淋巴结短径、术前SCC-Ag水平、NLR三者联合诊断的ROC曲线下面积为0.863。多指标(术前SCC-Ag水平、MRI淋巴结短径、肿瘤直径、间质浸润深度、宫旁浸润以及脉管浸润)联合诊断宫颈癌LNM的ROC曲线下面积为0.926。结论影像学检查与血清学指标和临床病理特征联合可以提高对宫颈癌淋巴结转移的预测价值。
- 宫颈癌 /
- 淋巴结转移 /
- 磁共振成像 /
- 鳞状细胞癌抗原 /
- 中性粒细胞与淋巴细胞比值
Abstract: Objective This study aims to investigate the predictive value of MRI combined with preoperative serological markers: squamous cell carcinoma antigen (SCC-Ag), neutrophil to lymphocyte ratio (NLR) and biopsy pathology in lymph node metastasis of early cervical cancer. Methods A total of 307 patients who underwent primary surgery in the First Affiliated Hospital of Bengbu Medical College from January 2019 to February 2022 were selected and divided into lymph node metastasis group (81 cases) and no lymph node metastasis group (226 cases) according to the presence or absence of lymph node metastasis after surgery. The MRI lymph node short diameter, tumour size, interstitial infiltration depth, parauterine and vaginal involvement, preoperative serological indices and pathological features of the 2 groups were compared. The predictive value of lymph node metastasis and the significance of combined diagnosis were analysed. Results Logistic regression analysis showed that large short diameter of MRI lymph nodes, large tumor diameter, depth of interstitial infiltration greater than 1/2 muscular layer, parametrial involvement, increased expression of SCC-Ag and positive vascular were independent risk factors for lymph node metastasis of cervical cancer (P < 0.05). The areas under the ROC curve of MRI lymph node diameter, SCC-Ag and NLR for the diagnosis of cervical cancer LNM were 0.806, 0.711 and 0.630, respectively. The optimal cut-off values were 8.50 mm, 2.55 ng/mL and 1.90, respectively. The sensitivity values were 0.654, 0.593 and 0.593, respectively, and the specificity values were 0.881, 0.757 and 0.642, respectively. The area under the ROC curve of MRI lymph node short diameter combined with SCC-Ag diagnosis was 0.846. The area under ROC curve for the combined diagnosis of MRI lymph node short diameter, SCC-Ag and NLR was 0.863. The area under ROC curve of multiple indicators (SCC-Ag, MRI lymph node short diameter, tumour size, interstitial infiltration depth, parauterine involvement, and vascular positive) for combined diagnosis of cervical cancer LNM was 0.926. Conclusion Imaging examination (MRI) combined with serological indicators and clinicopathological features can improve the predictive value of cervical cancer lymph node metastasis.
- Cervical cancer /
- Lymph node metastasis /
- Magnetic resonance imaging /
- Squamous cell carcinoma antigen /
- Neutrophil-lymphocyte ratio

HTML全文

图 1 不同指标诊断宫颈癌淋巴结转移的ROC曲线

注: 多指标包含MRI淋巴结短径、肿瘤直径、宫旁浸润、间质浸润深度、SCC-Ag、脉管浸润。

Figure 1. ROC curve of cervical cancer lymph node metastasis diagnosed by different indexes

下载: 全尺寸图片幻灯片

表 1 影响淋巴结转移的单因素分析

Table 1. Univariate analysis of influence on factors affecting lymph node metastasis

项目	转移组(81例)	未转移组(226例)	统计量	P值
年龄(x±s，岁)	49.98±7.84	52.19±9.82	1.827^a	0.069
分娩次数[M(P₂₅, P₇₅)，次]	2(2, 3)	2(2, 3)	-1.153^b	0.249
病程[M(P₂₅, P₇₅)，月]	3(1, 6)	3(1, 6)	-0.335^b	0.737
NLR[M(P₂₅, P₇₅)]	1.96(1.47, 2.72)	1.67(1.31, 2.10)	-3.479^b	＜0.001
MRI肿瘤直径[M(P₂₅, P₇₅), cm]	4.36(3.50, 5.15)	3.00(2.00, 3.60)	-7.510^b	＜0.001
MRI淋巴结短径[M(P₂₅, P₇₅), mm]	9.80(7.35, 11.35)	6.50(5.80, 7.30)	-8.182^b	＜0.001
术前SCC-Ag水平[M(P₂₅, P₇₅), ng/mL]	3.20(1.98, 5.45)	1.80(1.10, 2.50)	-5.638^b	＜0.001
肿瘤类型[例(%)]			0.069^c	0.793
内生型	60(74.1)	164(72.6)
外生型	21(25.9)	62(27.4)
MRI宫旁浸润[例(%)]			66.061^c	＜0.001
是	35(43.2)	12(5.3)
否	46(56.8)	214(94.7)
MRI阴道受累[例(%)]			24.380^c	＜0.001
是	52(64.2)	74(32.7)
否	29(35.8)	152(67.3)
脉管浸润[例(%)]			67.721^c	＜0.001
是	38(46.9)	15(6.6)
否	43(53.1)	211(93.4)
MRI间质浸润深度[例(%)]			33.760^c	＜0.001
< 1/2肌层	10(12.3)	111(49.1)
≥1/2肌层	71(87.7)	115(50.9)
临床分期[例(%)]			24.970^c	＜0.001
ⅠA	1(1.2)	17(7.5)
ⅠB	33(40.7)	146(64.6)
ⅡA	47(58.0)	63(27.9)
肿瘤细胞分化程度[例(%)]			5.545^c	0.062
Ⅰ	1(1.2)	18(8.0)
Ⅱ	48(59.3)	137(60.6)
Ⅲ	32(39.5)	71(31.4)
注：^a为t值，^b为Z值，^c为χ²值。

下载: 导出CSV

表 2 影响淋巴结转移的多因素分析

Table 2. Analysis of multiple factors affecting lymph node metastasis

变量	B	SE	Wald χ²	P值	OR(95% CI)
NLR	0.369	0.230	2.586	0.108	1.446(0.922~2.268)
MRI肿瘤直径	0.412	0.176	5.497	0.019	1.510(1.070~2.131)
术前SCC-Ag水平	0.117	0.059	3.892	0.049	1.124(1.001~1.263)
MRI宫旁浸润	1.067	0.529	4.076	0.044	2.908(1.032~8.195)
MRI阴道受累	0.000	0.441	0.000	0.999	1.000(0.421~2.375)
MRI间质浸润深度	1.102	0.514	4.602	0.032	3.010(1.100~8.236)
临床分期	0.001	0.406	0.000	0.998	1.001(0.452~2.219)
MRI淋巴结短径	0.486	0.088	30.340	＜0.001	1.626(1.367~1.932)
脉管浸润	1.988	0.465	18.301	＜0.001	7.298(2.936~18.142)
注：变量赋值如下, NLR、MRI肿瘤直径、SCC-Ag、MRI淋巴结短径以实际值进行赋值; MRI提示可疑宫旁浸润=1，MRI未提示可疑宫旁浸润=0；MRI提示阴道受累=1，MRI未提示阴道受累=0；MRI间质浸润深度 < 1/2肌层=0, MRI间质浸润深度>1/2肌层=1；临床分期ⅠA=0，ⅠB=1，ⅡA=2；有脉管浸润=1，无脉管浸润=0。

下载: 导出CSV

表 3 各指标的敏感度、特异度、阳性预测值、阴性预测值

Table 3. Sensitivity, specificity, positive predictive value and negative predictive value of each index

指标	灵敏度	特异度	阳性预测值(%)	阴性预测值(%)	95% CI
MRI淋巴结短径	0.654	0.881	66.3	87.7	0.744~0.868
术前SCC-Ag水平	0.593	0.757	46.6	83.8	0.644~0.778
NLR	0.593	0.642	37.2	81.5	0.556~0.705
MRI淋巴结短径联合SCC-Ag	0.765	0.823	60.8	90.7	0.794~0.898
MRI淋巴结短径、SCC-Ag联合NLR	0.778	0.850	64.3	91.4	0.814~0.912
多指标联合	0.877	0.872	71.0	95.2	0.893~0.960

下载: 导出CSV

参考文献(23)

[1]	张军. 宫颈癌治疗的现状及问题: 从临床指南到真实世界研究[J]. 中国全科医学, 2022, 25(3): 259-263. doi: 10.12114/j.issn.1007-9572.2021.02.105 ZHANG J. Current status and challenges of cervical cancer treatment: from clinical guidelines to real-world study[J]. Chinese General Practice, 2022, 25(3): 259-263. doi: 10.12114/j.issn.1007-9572.2021.02.105
[2]	陈一蕊, 勾朝阳, 李新阳. 血清SCC-Ag、sE-cadherin、β-HCG在宫颈癌诊断中的应用价值[J]. 实用癌症杂志, 2022, 37(3): 376-379. doi: 10.3969/j.issn.1001-5930.2022.03.007 CHEN Y R, GOU C Y, LI X Y. Value of Serum SCC-Ag, sE-cadherin and β-HCG in the diagnosis of cervical cancer[J]. The Practical Journal of Cancer, 2022, 37(3): 376-379. doi: 10.3969/j.issn.1001-5930.2022.03.007
[3]	胡玉峰, 程晓东. NLR、FAR、SCC-Ag对宫颈鳞状细胞癌患者术前淋巴结转移的预测价值[J]. 中国妇产科临床杂志, 2022, 23(3): 278-280. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202203018.htm HU Y F, CHENG X D. Predictive value of NLR, FAR and SCC-Ag in preoperative lymph node metastasis of patients with cervical squamous cell carcinoma[J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2022, 23(3): 278-280. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202203018.htm
[4]	MASRI A, STEINMETZ L, ROBINSON W R. Women with cervical carcinoma in pre-and post-katrina new orleans: a comparative analysis[J]. Gynecol Oncol, 2020, 156(3): 31-32.
[5]	周琦, 吴小华, 刘继红, 等. 宫颈癌诊断与治疗指南(第四版)[J]. 中国实用妇科与产科杂志, 2018, 34(6): 613-622. doi: 10.19538/j.fk2018060111 ZHOU Q, WU X H, LIU J H, et al. Guidelines to the diagnosis and treatment of cervical cancer (4th edition)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2018, 34(6): 613-622. doi: 10.19538/j.fk2018060111
[6]	COHEN P A, JHINGRAN A, OAKNIN A, et al. Cervical cancer[J]. Lancet, 2019, 393(10167): 169-182. doi: 10.1016/S0140-6736(18)32470-X
[7]	KAN Y Y, DONG D, ZHANG Y C, et al. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer[J]. J Magn Reson Imaging, 2019, 49(1): 304-310. doi: 10.1002/jmri.26209
[8]	周晖, 刘昀昀, 罗铭, 等. 《2021 NCCN子宫颈癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2020, 36(11): 1098-1104. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202011015.htm ZHOU H, LIU Y Y, LUO M, et al. Interpretation of the NCCN clinical practice guidelines for cervical cancer(2021. v1)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2020, 36(11): 1098-1104. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202011015.htm
[9]	洪士彬, 程杰军, 狄文. MRI在宫颈癌分期评估中的临床应用及研究进展[J]. 国际妇产科学杂志, 2021, 48(6): 634-638. https://www.cnki.com.cn/Article/CJFDTOTAL-GWVC202106008.htm HONG S B, CHENG J J, DI W. Advances and applications of MRI in Staging assessment of cervical cancer[J]. Journal of International Obstetrics and Gynecology, 2021, 48(6): 634-638. https://www.cnki.com.cn/Article/CJFDTOTAL-GWVC202106008.htm
[10]	TOMASSI M J, ABBAS M A, KLARISTENFELD D D. Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US health care system experience[J]. Int J Colorectal Dis, 2019, 34(1): 47-54. doi: 10.1007/s00384-018-3167-7
[11]	马梅, 晋茂生, 叶国柳. HPV分型、SCC-Ag与NLR联合对早期宫颈癌淋巴结转移的预测作用[J]. 中华全科医学, 2022, 20(4): 578-582. doi: 10.16766/j.cnki.issn.1674-4152.002404 MA M, JIN M S, YE G L. Predictive effect of HPV typing, SCC-Ag and NLR on lymph node metastasis of early cervical cancer[J]. Chinese Journal of General Practice, 2022, 20(4): 578-582. doi: 10.16766/j.cnki.issn.1674-4152.002404
[12]	LIU Z H, SHI H T. Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis[J]. Dis Markers, 2019, 2019: 6710352. DOI: 10.1155/2019/6710352.
[13]	李丹, 徐小仙, 闫鼎鼎, 等. 早期宫颈鳞状细胞癌患者检测血清鳞状细胞癌抗原的临床意义[J]. 中华肿瘤杂志, 2019, 41(5): 357-362. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202123018.htm LI D, XU X X, YAN D D, et al. Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma[J]. Chinese Journal of Oncology, 2019, 41(5): 357-362. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202123018.htm
[14]	张冬雅, 郭红军. 18F-FDG PET-CT联合血清SCC-Ag检测对宫颈癌盆腔淋巴结转移的诊断价值[J]. 中国CT和MRI杂志, 2019, 17(3): 105-108, 153. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR201903032.htm ZHANG D Y, GUO H J. Value of 18F-FDG PET-CT combined with serum SCC-Ag in diagnosing pelvic lymph node metastasis of cervical cancer[J]. Chinese Journal of CT and MRI, 2019, 17(3): 105-108, 153. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR201903032.htm
[15]	秦琳, 吴玉梅, 王明, 等. 增强CT淋巴结短径及SCC-Ag在术前预测宫颈鳞癌淋巴结转移中的应用[J]. 中国医药导报, 2022, 19(5): 124-128. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202205028.htm QIN L, WU Y M, WANG M, et al. Application of the shortest diameter of lymph nodes in enhanced CT and SCC-Ag predicting pre-operation lymph node metastasis in cervical squamous cell carcinoma[J]. China Medical Herald, 2022, 19(5): 124-128. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202205028.htm
[16]	张文静, 田红梅, 王冲, 等. NLR、PLR对结肠癌根治术后手术部位感染的预测价值[J]. 分子诊断与治疗杂志, 2022, 14(2): 245-248. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYQ202202016.htm ZHANG W J, TIAN H M, WANG C, et al. Predictive value of NLR and PLR for surgical site infection after radical resection of colon cancer[J]. Journal of Molecular Diagnostics and Therapy, 2022, 14(2): 245-248. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYQ202202016.htm
[17]	ZHU M L, FENG M, HE F, et al. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer[J]. Clin Chim Acta, 2018, 483: 296-302.
[18]	梅冰洁, 张国楠. 中性粒细胞、血小板与淋巴细胞比值对中晚期宫颈癌患者预后的评估价值[J]. 现代妇产科进展, 2019, 28(12): 892-895. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201912003.htm MEI B J, ZHANG G N. Prognostic value of neutrophil, platelet to lymphocyte ratio in patients with advanced cervical cancer[J]. Progress in Obstetrics and Gynecology, 2019, 28(12): 892-895. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201912003.htm
[19]	赵雅文, 董頔, 薛茜文, 等. 术前外周血中NLR、PLR、LMR与早期宫颈癌患者预后的相关性研究[J]. 新疆医科大学学报, 2020, 43(8): 997-1003. https://www.cnki.com.cn/Article/CJFDTOTAL-XJYY202008004.htm ZHAO Y W, DONG D, XUE Q W, et al. Correlation between NLR, PLR and LMR in preoperative peripheral blood and prognosis of patients with early cervical cancer[J]. Journal of Xinjiang Medical University, 2020, 43(8): 997-1003. https://www.cnki.com.cn/Article/CJFDTOTAL-XJYY202008004.htm
[20]	王金凤, 李琛, 黄康榕, 等. 术前中性粒细胞和淋巴细胞比值、单核细胞和淋巴细胞比值与宫颈癌患者临床病理特征的相关性[J]. 兰州大学学报(医学版), 2019, 45(5): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX201905008.htm WANG J F, LI C, HUANG K R, et al. Correlation between preoperative neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and clinical pathologic features in patients with cervical cancer[J]. 兰州大学学报(医学版), 2019, 45(5): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX201905008.htm
[21]	乌云, 苏俊玲, 杜洁, 等. 宫颈癌临床病理特征与宫旁侵犯及盆腔淋巴结转移的关系研究[J]. 局解手术学杂志, 2019, 28(12): 969-972. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ201912009.htm WU Y, SU J L, DU J, et al. Correlation study of clinicopathologic features with parametrial invasion and pelvic lymph node metastasis in cervical cancer patients[J]. Journal of Regional Anatomy and Operative Surgery, 2019, 28(12): 969-972. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ201912009.htm
[22]	蔡斌, 吴昊, 丰有吉, 等. 100例宫颈癌临床病理特征与宫旁侵犯和盆腔淋巴结转移的关系分析[J]. 实用妇产科杂志, 2015, 31(5): 366-368. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201505019.htm CAI B, WU H, FENG Y J, et al. Correlation between the clinical pathology characteristic and parametrial involvement or pelvic lymph node metastasis in 100 cases of cervical cancer[J]. Journal of Practical Obstetrics and Gynecology, 2015, 31(5): 366-368. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201505019.htm
[23]	周晖, 王东雁, 罗铭, 等. 《FIGO 2018妇癌报告》: 子宫颈癌指南解读[J]. 中国实用妇科与产科杂志, 2019, 35(1): 95-103. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202205014.htm ZHOU H, WANG D Y, LUO M, et al. FIGO 2018 Women's Cancer Report: Interpretation of cervical cancer Guidelines[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2019, 35(1): 95-103. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202205014.htm